Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cervix carcinoma
|
283 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.700 | 0 | |||||||||
Li-Fraumeni Syndrome
|
206 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.700 | 0 | |||||||||
ovarian neoplasm
|
757 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.700 | 0 | |||||||||
Liver neoplasms
|
7 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 1994 | 1994 | ||||||
Hepatoblastoma
|
22 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Hepatocellular Adenoma
|
7 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Multiple adenomatous polyps
|
5 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Chronic liver disease
|
14 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Congenital absence of liver
|
2 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Primary Malignant Liver Neoplasm
|
4 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Neoplasms
|
1644 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.050 | 1.000 | 5 | 2001 | 2013 | ||||||
Cirrhosis
|
110 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||
Hepatocarcinogenesis
|
24 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.020 | 1.000 | 2 | 2010 | 2013 | ||||||
Liver Cirrhosis
|
189 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||
Liver diseases
|
100 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Fibrosis, Liver
|
64 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Gallbladder Carcinoma
|
75 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
gallbladder neoplasm
|
6 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Malignant neoplasm of gallbladder
|
81 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.010 | 1 | 2017 | 2017 | |||||||
Adult Liver Carcinoma
|
72 | 0.645 | 0.360 | 17 | 7674216 | missense variant | C/A;G | snv | 0.030 | 1.000 | 3 | 2018 | 2019 |